å½æ°çæ´»ã»ã³ã¿ã¼ãå¸è²©ã®æ°´ç´ æ°´ããã¹ãããå«ã¾ãã¦ããæ°´ç´ ã表示ãããæ¿åº¦ãä½ããã£ããããããã¯æ¤åºãããªãã£ãååãããã¨çºè¡¨ãããã¾ããå¥åº·ä¿æå¢é²å¹æã謳ããã®ããããæ³å¾ã«æµè§¦ãããããã®ããããäºæ¥è ã«å¯¾ã表示ã®æ¹åãè¦æãã¦ããã
æ°´ç´ æ°´ãã¼ã ãçµããã¤ã¤ããããã«è¦ãããå®å ¨ã«ãªããªãã¯ããªãã ããããã¼ã¡ã¼ã¡æ¬¡ã®ä½ããæµè¡ãé ã§ã¯ãªãã ããããç¾æç¹ã§ã¯ãç æ°ã®äºé²ãå¥åº·ã®ç¶æã®ç®çã§å¥åº·ãªäººãæ°´ç´ æ°´ã飲ãã§ä½ããã®ããå¹æãããã¨ããè¨åºç証æ ã¯ãªãããã ãä½ããããã¨ããããããããªãã¨ããå¯è½æ§ã«ãéãè²»ããã®ã¯å人ã®èªç±ã§ããã
ç§èªèº«ã¯ãæ°´ç´ æ°´ã«å¯¾ãã¦ãã¾ãç©æ¥µçãªæ¹å¤ã¯ãã¦ããªãã£ããçç±ã®ä¸ã¤ã¯ãæ°´ç´ æ°´ã¯æ¨æºå»çãå¦å®ãããã»ã¼å®å ¨ã§ãå®ä¾¡ã ããã§ãããæ®éã®æ°´ã¨æ¯è¼ããã¨é«ä¾¡ã ããæ°ååããã¨ãã«ã¯æ°ç¾ä¸åãããä»ã®ããã»å»å¦ãã¨æ¯è¼ããã°å®ããã®ã§ãããããããå人å人ã®è² æ ããè²»ç¨ã¯å®ãããããã¾ã§ã®ãã¼ã ã«ãªãã¨ç¤¾ä¼å ¨ä½ã§ã®ã³ã¹ãã¯é¦¬é¹¿ã«ãªããªããããããªãã
æ°´ç´ æ°´ãç©æ¥µçã«æ¹å¤ããªãã£ãããä¸ã¤ã®çç±ã¯ãæ°´ç´ æ°´ã«å¹æãããå¯è½æ§ãå®å ¨ã«ã¯å¦å®ã§ããªãããã§ããããããã»å»å¦ãã«é¨ãããªãããã«ãã§ã¯ãä½è³ªæ¹åãç æ°ãæ²»ãã¨ç§°ãããæ°´ãã«å¯¾ããæ¹å¤ã«ä¸ç« ãå²ãã¦ããããã¢ã«ã«ãªã¤ãªã³æ°´ã¨æ°´ç´ æ°´ãä¾å¤ã«ãããã¢ã«ã«ãªã¤ãªã³æ°´ã¯èè ¸çç¶ãæ¹åãããã¨ããéå®çãªè¨¼æ ãããã
æ°´ç´ æ°´ã«ã¤ãã¦ã¯è¤æ°ã®è¨åºè©¦é¨ãé²è¡ä¸ã§ãçµäºãããã®ããããâ UMINè¨åºè©¦é¨ç»é²ã·ã¹ãã (UMIN-CTR)ã§æ¤ç´¢ããã¨ã2016å¹´12æ26æ¥æç¹ã§18件ã®è¨åºè©¦é¨ãç»é²ããã¦ãããä¸ã«ã¯è³ªã®é«ããã¶ã¤ã³ã®äºéç²æ¤ã©ã³ãã åæ¯è¼è©¦é¨ããããæ°´ç´ æ°´ã«è¦è¾¼ã¿ãããã¨èãããã¦ãããããããã³ã¹ããããã¦è¨åºè©¦é¨ãè¡ããã¦ããã®ã ã
è¨åºè©¦é¨ç»é²ã·ã¹ãã ä¸ã§2件ã ãçµæã®è¨è¼ããã£ããUMIN試é¨ID:UMIN000005779ã¯ãå¥å¸¸è æ人ã対象ã«ãæ°´ç´ ã¬ã¹ã溶解ããã¦è£½é ããã水製åï¼å¥åº·é£²æï¼ã®é£²ç¨ã«ããã被é¨è ã®é ¸åã¹ãã¬ã¹ãæ¸å°ããããæããã«ããããã¨ãç®çã«æ½è¡ãããããæ°´ç´ æ°´ç¾¤ã¨å¯¾ç §ã®æ°´é水群ã®æ¯è¼ã§ãè¡ä¸ã»å°¿ä¸ã®é ¸åã¹ãã¬ã¹ææ¨ç©è³ªã«ææãªå¤åãªããã§ãã£ãã
UMIN試é¨ID:UMIN000007497ã§ã¯ããæ°´ç´ æ°´æåã«ãããã¼ãã³ã½ã³ç ã®é²è¡æå¶å¹æåã³çç¶æ¹åå¹æãå¾ããããæ¤è¨ãããã¨ãããææãªå·®ãèªãã*1ãUPDRSã¹ã³ã¢ã¨ãããã¼ãã³ã½ã³ç ã®çç¶ãç¹æ°ã§è©ä¾¡ãããã®ããæ°´é水群ã¯+4.5ã¨æªåããã®ã«æ¯ã¹æ°´ç´ 水群ã§ã¯-1.0ã¨æ¹åãããè¨åºè©¦é¨ç»é²ã·ã¹ãã ä¸ã§ã¯çµæã¯æªå ¬è¡¨ã¨ãªã£ã¦ããããPubmedã§æ¤ç´¢ããã¨è«æã«ãªã£ã¦ãã*2ãããã¯äºåå®é¨ãªã®ã§ããµã³ãã«ãµã¤ãºã大ãããã¦è¿½è©¦ãè¡ããã¦ããããã§ãã*3ã
æ°´ç´ æ°´ã®é£²ç¨ããã¼ãã³ã½ã³ç ã®çç¶æ¹åã«æ¬å½ã«æå¹ãã©ãããå人çã«ã¯æççãªç«å ´ã«ç«ã¤ããã¼ãã³ã½ã³ç ã«é ¸åã¹ãã¬ã¹ãé¢ä¸ããã®ã¯ç¢ºããªããã§ããããæ°´ç´ ååã«ãã£ã¦é ¸åã¹ãã¬ã¹ã軽æ¸ããã°å¹æãæå¾ ã§ããã¨ããã®ãããããä¸æ¹ã§ãæ°´ã«æº¶ããå°ãªãéã®æ°´ç´ ã§ãå¹æãåºãã®ã ããããè¨åºè©¦é¨ãæ°å¤ãè¡ãã°ããã¾ãã¾å¶ç¶ã«ææå·®ãçãããã¨ãããã®ã§ã¯ã
ããããçµå±ã®ã¨ããããã£ã¦ã¿ãªããã°ããããªãã®ãè¨åºè©¦é¨ã§ãããæ°´ã«ã¯æ°´ç´ ã¯ã»ã¨ãã©æº¶ããæ°´ç´ æ°´ã«å«ã¾ããæ°´ç´ ã®éãå°ãªãã¨ãã¦ããæ¯æ¥é·æéæåããã°å¹æãããã¨ããå¯è½æ§ãããããã¼ãã³ã½ã³ç ã«å¯¾ããæ°´ç´ æ°´ã®å¹æã¯è¿½è©¦ã®çµæãå¾ ã¤ãããªããä»ã®æ²»çæ³ã¨åãããè¯ãçµæãåºãã°è¨åºã«å¿ç¨ãããã ããããçµæãåºãªããã°ãªãã¨ãªãå¿ãå»ãããã§ãããã
ããã¾ã§èªã¾ãã¦ãã¡ã¾ãã§è¨ããã¦ããã»ã©æ°´ç´ æ°´ã¯ãã»ç§å¦çã§ã¯ãªããæå¤ã«æå¾ ãæã¦ãã¨æããèªè ãããã§ããããæ°´ç´ æ°´ã®ä¸å¹¸ã¯ãè¨åºçã«å¹æã確èªãããåã«ãä¸è½çãªå¹æãæå¾ ããã¦å¸å ´ã§è²©å£²ããããã¨ã«ããããã¼ãã³ã½ã³ç ã«å¹æããããããããªãã¨ãã話ã¨ãå¥åº·ãªäººãæ°´ç´ æ°´ã飲ãã§ä½ã«ãããã¨ãã話ã¯ããããå¥ã§ããã
æªå¾³æ¥è ãåæã«å¹æã謳ã£ã¦æ°´ç´ æ°´ã販売ããã®ã§ããã°ãç 究è å´ã¯è¢«å®³è ã§ãããããããæ°´ç´ æ°´ã®å ´åãæå°çãªç«å ´ã®ç 究è ã§ããæ¥æ¬å»ç§å¤§ã®å¤ªç°æç·ææãç©æ¥µçã«æ°´ç´ æ°´ãã¸ãã¹ã«é¢ä¸ããè¨åºç証æ ã«ä¹ããã¾ã¾ãè±ç²çã軽ããªãããå¯è¦ãããããªãããå·ãæ§ãæ¹åãããã¨ãã£ã宣ä¼ã«ååãã¦ãããæ§ããã«è¨ã£ã¦è»½çã§ãããæ ¹æ ãªããå¹æãç§å¦çã«è¨¼æããããã¨ä¸»å¼µããã°ããã»ç§å¦ã¨è¨ã£ã¦ãããã¨æãã
æ°´ç´ æ°´ãã¼ã ãå»ããæ°´ç´ æ°´ã®å¹æãããã®ããªãã®ããããã¨ãããä½ã«å¯¾ãã¦ã©ããããã®å¹æãããã®ããæ£ç¢ºã«è©ä¾¡ããå
¬è¡¨ããããã¨ãæå¾
ãã¦ããã
å¤é¨ãªã³ã¯
â æ°´ç´ æ°´ãããã»ç§å¦ãã¨åãæ¨ã¦ã¦ã¯ãããªãããã¨ããã³ã¹ããã¨ã¯è¨ãé£ã | FOOCOM.NET
â ãæ°´ç´ æ°´ãæ¥æ¬å»ç§å¤§ã®å¤ªç°æç·ææã®ä¸»å¼µã«ã¯æãããªèª¤èªããããå
¬ç財å£æ³äººé£ã®å®å
¨ã»å®å¿è²¡å£çäºé·ã»åæ¨è±æï¼æ±å¤§åèªææï¼ï¼1/3ãã¼ã¸ï¼ - ç£çµãã¥ã¼ã¹
é¢é£è¨äº
â ããã»å»å¦ãã«ã¤ãã¦ã®æ¬ãæ¸ãã¾ãã
â ä½ã§ãæ²»ãè¶
ããã©ã«æ°´ãé島å°æ¦å士ãç±ãï¼
*1:"The total UPDRS score of the H2-water group (n = 9) improved-1.0 (median), -5.7+- 8.4 (mean +- SD)], whereas that of the placebo group (n = 8) worsened [4.5, 4.1 +- 9.2]. Despite the minimal number of subjects and the short duration of the trial, the difference was significant (P < 0.05). "